Skip to content

How to Register Weight Loss Pills and Medicines in the UAE: Guidelines for the Pharma Companies


How to Register Weight Loss Pills and Medicines in the UAE - Hawkridge corp

The demand for weight loss pills and medicines is increasing at a fast pace in the UAE. In view of escalating numbers of obese people, new age therapies like GLP-1 agonist drugs that have attracted considerable attention on account of their commercial success all over the world, pharma companies are now eyeing the UAE market for their weight loss products. This is because it is a highly regulated industry and regardless of whether you are dealing with a weight loss prescription drug, an OTC tablet or a dietary supplement meant for weight reduction purposes, there is a unique process of registration in the UAE. This guide explains exactly how weight loss pills and medicines are classified, which authority regulates them, and what the registration process involves in 2026 and beyond.

Why Product Classification Is the Most Critical First Step

Before you can register any weight loss product in the UAE, you must determine what regulatory category it falls into. Weight loss pills and related products can sit in three entirely different regulatory categories depending on their active ingredients, mechanism of action, and the claims made on the label. Getting this classification wrong is the single most common reason applications are delayed, rejected, or returned for reclassification.

The three possible classifications for weight loss pills and medicines in the UAE are:

  • Prescription pharmaceutical: Products containing approved active pharmaceutical ingredients (APIs) with a proven clinical mechanism for weight loss  such as orlistat, semaglutide, or tirzepatide. These are regulated as regular drugs and require the most extensive registration dossier
  • Over-the-counter (OTC) medicine: Weight loss tablets which do not require a prescription, with specific ingredients that have been authorized for general sale purposes. They fall in the category between prescription drugs and food supplements and require drug registration through the OTC route
  • Food supplement: Food products that contain vitamins, mineral, herbal ingredients or any other form of nutrient with an intention to aid weight loss e.g. green tea extract, CLA or glucomannan. They are not regulated as medicines but require product registration before they can be marketed in the UAE

Which Regulatory Body in UAE Controls Weight Loss Medications?

The regulatory system for medicines in the UAE has gone through a total change as a result of the establishment of Emirates Drug Establishment (EDE) through the Federal Decree-Law No. 38 of 2024. It is extremely important to be aware of the regulatory authority that regulates your weight loss drug product.

Emirates Drug Establishment (EDE): Prescription & OTC Drugs

The EDE is the main federal regulatory agency for the registration of drugs in UAE, including prescription weight loss drugs and OTC weight loss tablets. From December 2025, 44 core pharmaceutical registration services that were previously managed by MOHAP transferred to the EDE, which operates through its dedicated portal at www.ede.gov.ae. If your weight loss product is classified as a prescription medicine to lose weight such as a GLP-1 receptor agonist, an appetite suppressant, or a fat absorption inhibitor the EDE is your registration authority.

An important procedural point: Marketing Authorisation Holder (MAH) companies must still be registered with MOHAP before submitting any product applications through the EDE. This MOHAP company registration step is a prerequisite, not optional.

MOHAP: Medicated Supplements and General Sale Weight Loss Products

MOHAP continues to handle registration for certain categories of weight loss products that sit between standard food supplements and regulated medicines. These include products classified as “general sale pharmaceutical products” such as medicated slimming teas, herbal weight management formulations with pharmacological claims, or combination products. MOHAP also retains jurisdiction over community pharmacies that stock and dispense weight loss medicines at the retail level.

DHA and DOH: Emirate-Level Formulary Approvals

For weight loss pills and medicines to be prescribed and dispensed through healthcare facilities in Dubai, they must also appear on the Dubai Health Authority (DHA) approved formulary. Similarly, for Abu Dhabi facilities, registration with the Department of Health (DOH) is required. These emirate-level approvals sit on top of the federal EDE or MOHAP registration you need both. Companies launching prescription weight loss medicines in the UAE should factor DHA and DOH formulary submissions into their market access planning from the outset.

Current Scenario: What Are the Weight Loss Drugs Available in UAE?

The UAE’s weight loss pill and drugs market has witnessed a lot of changes in recent years, owing to the increasing trend of GLP-1 receptor agonists globally. Here is an overview of the main categories currently active in the UAE market:

GLP-1 and Dual-Agonist Weight Loss Medicines

Semaglutide (sold under the brand names Ozempic and Wegovy) and trizepatide (Mounjaro) are the highest-profile prescription weight loss medicines globally and are available in the UAE through licensed medical providers. Semaglutide is approved by MOHAP/EDE for chronic weight management. Oral semaglutide (Wegovy pill) received US FDA approval in December 2025 and is anticipated to move through UAE approval channels under EDE review. Tirzepatide (a dual GLP-1 and GIP receptor agonist) has demonstrated superior weight loss outcomes in clinical studies and is also progressing through UAE regulatory pathways. These medicines require a full pharmaceutical dossier for registration in the UAE and are dispensed by prescription only through licensed healthcare providers.

OTC Weight Loss Tablets

Over-the-counter weight loss tablets registered in the UAE include products such as orlistat 60mg (available in some markets without prescription), various lipase inhibitor formulations, and certain fibre-based appetite management tablets. The OTC pathway for weight loss pills requires a conventional pharmaceutical dossier, though the clinical data requirements may differ from those for prescription-only medicines. UAE regulators apply strict scrutiny to OTC weight loss claims; any suggestion of a clinical mechanism will typically trigger reclassification to the prescription pathway.

Food Supplements Positioned for Weight Management

Weight management food supplements registered in the UAE include products such as conjugated linoleic acid (CLA), green tea and caffeine combination tablets, glucomannan-based fibre supplements, thermogenic formulations, and meal replacement products. These do not require a pharmaceutical dossier but do need full food supplement registration with MOHAP, including ingredient review, labelling assessment, and claim validation. Supplement registrations for weight loss products are valid for three years and must be renewed.

Documents that will be Needed for Registration of Weight Loss Pills in the UAE

These documents will depend on the regulatory route your weight loss pill will take. The list below will indicate the documents needed in each of the categories:

Prescription and OTC Weight Loss Medications (EDE Route)

  • Full CTD/eCTD Dossier: Full Common Technical Document from Modules 1 through 5 that contain administrative information, overview of clinical aspects, quality information, nonclinical information, and clinical trial information.
  • Certificate of Free Sale (CFS): Certified document that proves the weight loss drug has been authorized and marketed in the manufacturing country
  • Good Manufacturing Practices Certificate (GMP): An up-to-date GMP certificate for the manufacturing facility from an accredited regulatory body
  • Bioequivalence or bioavailability study: Bioequivalence or bioavailability data of the generic weight loss tablets
  • Stability study: Stability studies in accordance with ICH recommendations to support shelf-life and storage conditions proposed for the UAE climate zone
  • Pharmacovigilance plan: Documented risk management and adverse events monitoring plan, which includes the appointment of a locally designated Pharmacovigilance Officer
  • Marketing authorisation holder registration: The approval of the MAH entity based in UAE, registered with MOHAP before EDE submission
  • Manufacturer registration
  • Arabic and English product labeling: Bilingual product labeling and leaflet conforming to UAE and ESMA labeling requirements

For Weight Management Food Supplements (MOHAP Pathway)

  • Product dossier: Ingredient list with formulation information and description of product function
  • Certificate of Free Sale and GMP certificate: Similar as above, notarized and authenticated as needed
  • Safety data: Safety profile for all ingredients, especially any novel or high concentration herbal extract ingredients
  • Stability data: Supporting the shelf-life and storage claim
  • Halal certificate: Issued by a UAE-recognized certification body for supplements that are to be marketed in UAE
  • Label artwork: Labels in both Arabic and English with all information mandated on the label including amount of each ingredient per serving and reference value per day with disclaimer stating product is not a medicine for weight loss

UAE Registration Process for Weight Loss Pills and Drugs: Step by Step Guide

  1. Product Classification identify which category your product belongs to whether prescription drug, over-the-counter medicine or dietary supplement by active components, action and claims
  2. Medical warehouse and drug store activity
  3. Pharmaceutical facility license
  4. Register your company as Marketing Authorisation Holder (MAH) in MOHAP this is a mandatory step for EDE pharmaceuticals registration and MOHAP supplements registration process
  5. Assign UAE licensed medical warehouse or authorized representative as MAH if you are an overseas company foreign companies cannot be holders of UAE marketing authorizations
  6. Format your dossier in the correct format for pharmaceutical products, CTD/eCTD, and the standard product dossier for supplements ensuring that all the documents are notarized, apostilled, and either in Arabic or English as required
  7. Submit your application through the EDE portal (www.ede.gov.ae) for pharmaceutical products, or through the MOHAP portal (mohap.gov.ae) for supplements, along with the registration fees
  8. Provide your response to all the queries made by the technical review committee within the 30-day period; incomplete response to any queries is the main reason for delaying the registration of weight loss products
  9. Once approved, your product registration certificate will be issued. Pharmaceutical certificates have a validity period of five years while that of supplement certificates is three years and your product can now be legally imported into and marketed in UAE.
  10. DHA and DOH formulary applications should be submitted simultaneously if your weight loss medication needs prescription access through Dubai or Abu Dhabi medical centers

How Hawkridge Corp Helps You Register Weight Loss Products in the UAE

The process of registering weight loss pills and medicines in the UAE is governed by the multi-tiered regulatory structure that has undergone tremendous changes since the formation of the EDE in December 2025. At Hawkridge Corp, our regulatory affairs team has current, hands-on experience with both the EDE pharmaceutical pathway and the MOHAP supplement registration process and we understand the classification nuances that make weight loss products one of the more complex categories to register correctly.

We support pharmaceutical companies, supplement brands, and international manufacturers with product classification advisory, CTD/eCTD dossier preparation and review, MAH setup and MOHAP company registration, claim assessment and label review, EDE and MOHAP portal submission management, query response preparation, and DHA/DOH formulary support. We also assist clients with post-registration services including pharmacovigilance officer appointment, renewal management, and variation applications when formulations or label changes are needed.

Whether you are bringing a next-generation prescription weight loss medicine to the UAE market, registering a new OTC weight loss tablet range, or seeking approval for a food supplement positioned for weight management, Hawkridge Corp provides the regulatory expertise to guide your product from dossier to approval efficiently, accurately, and fully aligned with the UAE’s current regulatory requirements.

Final Thoughts

The UAE represents a significant commercial opportunity for companies bringing weight loss pills and medicines to market in the Middle East. But the regulatory pathway is more complex than many companies expect particularly with the transition of pharmaceutical registration services to the EDE, the heightened scrutiny applied to weight loss product claims, and the need for both federal and emirate-level approvals for prescription products. Getting classification right from the start, preparing a complete and claim-compliant dossier, and understanding the current roles of the EDE, MOHAP, DHA, and DOH are the foundations of a successful market entry strategy. With the right regulatory partner and the right preparation, registering weight loss products in the UAE is an entirely achievable milestone and the growing UAE market for effective, licensed weight management solutions makes it well worth the investment.